Contacto
Campos de conocimiento
Bioquímica
Reconocimiento Molecular y Bioestructura
Líneas de investigación
Química de proteínas. Química y metabolismo de lípidos. Cinética enzimática
Publicaciones
112. Toledo-Ibelles P and Mas-Oliva J,
Antioxidants in the fight against atherosclerosis: is this a dead end?
Current Atherosclerosis Reports 20:36 (2018). doi.org/10.1007/s11883-018-0737-7
113. Acosta-Montaño P, Ibarra-López E, Mas-Oliva J, Delgado-Coello B , Rivero I,
Alatorre-Meda M , Aguilera J , Rodríguez-Velázquez E, Guevara-Olaya E and García-
González V.
Fatty acid and lipopolysaccharide effect on beta cells proteostasis and its
impact on insulin secretion.
Cells 2019, 8(8), 884; doi.org/10.3390/cells8080884
114. Martínez-Navarro, I.; Díaz-Molina, R.; Pulido A.; Mas-Oliva, J.; Luna-Reyes, I.;
Rodríguez-Velázquez, E.; Rivero, I.A.; Ramos-Ibarra, M.A.; Alatorre-Meda, M.;
García-González, V.
Lipid Modulation in the Formation of β-Sheet Structures.
Implications for de Novo Design of Human Islet Amyloid Polypeptide and the Impact
on β-Cell Homeostasis.
Biomolecules 10(9); 1201 (2020) doi.org/10.3390/biom10091201
115. Mas-Oliva J.
Molecular events involved in the efficacy of therapeutic vaccine HB-ATV-8.
Atherosclerosis 315; E138 (2020)
doi.org/10.1016/j.atherosclerosis.2020.10.426 (Summary).
116. Luna-Reyes I, Pérez-Hernández E, Ávila-Rodríguez M.A. and Mas-Oliva J.
Peptide VSAK maintains tissue glucose uptake and attenuates pro-inflammatory
responses caused by LPS in an experimental model of the systemic inflammatory
response síndrome. A PET study.
Scientific Reports 11(1);1-13 (2021) doi.org/10.1038/s41598-021-94224
117. Pérez-Hernández E, Luna-Reyes I, Delgado-Coello B, and Mas-Oliva J.
An Insight on the Mechanisms for Lipopolysaccharide Inactivation in Sepsis.
Biomedicine & Pharmacotherapy 141; 111890 (2021)
doi.org/10.1016/j.biopha.2021.111890.
118. Briones-Orta M, Delgado-Coello B, Gutiérrez-Vidal R, Sosa-Garrocho M, Macias-
Silva, M, and Mas-Oliva, J.
Quantitative expression of key cancer markers in the AS-30D hepatocarcinoma model.
Frontiers in Oncology 11:670292. (2021) Manuscript Id: 670292
doi: 10.3389/fonc.2021.670292
119. Toledo-Ibelles P, Gutiérrez-Vidal R, Calixto-Tlacomulco S, Delgado-Coello B and
Mas-Oliva J.
Hepatic Accumulation of Hypoxanthine: A Link Between Hyperuricemia
and Nonalcoholic Fatty Liver Disease,
Archives of Medical Research 52:692-702 (2021)
doi.org/10.1016/j.arcmed.2021.04.005
120. Luna-Reyes I, Pérez-Hernández E, Delgado-Coello B, and Mas-Oliva J.
Peptides as therapeutic molecules to neutralize Gram-negative bacterial
lipopolysaccharides in sepsis and septic shock,
Archives of Medical Research 52.798-807 (2021)
doi.org/10.1016/j.arcmed.2021.08.001.
J. Mas-Oliva. Guest Editor in Special Issue “Sepsis” (portada)
121. Mas-Oliva J.
On the Right Track to Decoding the Enigma of Sepsis.
Archives of Medical Research, 52, 775-776 (2021)
doi.org/10.1016/j.arcmed.2021.09.001.
J. Mas-Oliva. Guest Editor of Special Issue “Sepsis” (portada)
122. Pérez-Hernández E, De la Puente-Díaz de León V, Luna-Reyes I, Delgado-Coello B,
Sifuentes-Osornio J, Mas-Oliva J.
Promising new targets and biomarkers for sepsis:
CETPI and derived peptides.
Molecular Medicine 28, 157 (2022).
https://doi.org/10.1186/s10020-022-00585-3
123. Nambo-Venegas, R.; Palacios-González, B.; Mas-Oliva, J.; Aurioles-Amozurrutia,
A.K.; Cruz-Rangel, A.; Moreno, A.; Hidalgo-Miranda, A.; Rodríguez-Dorantes, M.;
Vadillo-Ortega, F.; Xicohtencatl-Cortes, J.; Ruiz-Olmedo, M.I.; Reyes-Grajeda, J.P.
Conversion of M1 Macrophages to Foam Cells: Transcriptome Differences
Determined by Sex.
Biomedicines 11, 490 (2023).
https://doi.org/10.3390/biomedicines11020490
124. Mauricio Carrillo-Tripp, Yair Reyes, Blanca Delgado-Coello, Jaime Mas-Oliva,
Roxana Gutiérrez-Vidal.
Peptide Helix-Y12 as Potential Effector for Peroxisome Proliferator-Activated
Receptors.
PPAR Research, vol. 2023, Article ID 8047378, (2023).
https://doi.org/10.1155/2023/8047378
